ES2517190A1 - Canine mammary inflammatory carcinoma cell line (Machine-translation by Google Translate, not legally binding) - Google Patents

Canine mammary inflammatory carcinoma cell line (Machine-translation by Google Translate, not legally binding) Download PDF

Info

Publication number
ES2517190A1
ES2517190A1 ES201400512A ES201400512A ES2517190A1 ES 2517190 A1 ES2517190 A1 ES 2517190A1 ES 201400512 A ES201400512 A ES 201400512A ES 201400512 A ES201400512 A ES 201400512A ES 2517190 A1 ES2517190 A1 ES 2517190A1
Authority
ES
Spain
Prior art keywords
cell line
mammary
inflammatory
canine
inflammatory carcinoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201400512A
Other languages
Spanish (es)
Other versions
ES2517190B2 (en
Inventor
Juan Carlos ILLERA DEL PORTAL
Laura PEÑA FERNÁNDEZ
Sara CÁCERES RAMOS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Complutense de Madrid
Original Assignee
Universidad Complutense de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Complutense de Madrid filed Critical Universidad Complutense de Madrid
Priority to ES201400512A priority Critical patent/ES2517190B2/en
Publication of ES2517190A1 publication Critical patent/ES2517190A1/en
Application granted granted Critical
Publication of ES2517190B2 publication Critical patent/ES2517190B2/en
Priority to PCT/ES2015/000080 priority patent/WO2015197884A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • C12N5/063—Kereatinocyte stem cells; Keratinocyte progenitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Canine mammary inflammatory carcinoma cell line. The present invention relates to an established cell line of canine mammary inflammatory carcinoma, of triple negative basal epithelial cells. The invention also relates to a method for obtaining stable xenotransplantation of canine mammary inflammatory carcinoma in experimental animals, and to the use of the cell line and xenotransplantation in the study of canine mammary inflammatory carcinoma as well as of human inflammatory mammary carcinoma. And its use to identify in vitro therapeutically useful compounds for the treatment of human mammary inflammatory cancer. It also refers to a kit for the in vitro study of canine bmi and/or human ibc and potentially usable drugs against human ibc, which includes the cell line of the invention. (Machine-translation by Google Translate, not legally binding)

Description

imagen1image 1

imagen2image2

imagen3image3

imagen4image4

imagen5image5

imagen6image6

imagen7image7

imagen8image8

imagen9image9

imagen10image10

imagen11image11

imagen12image12

imagen13image13

imagen14image14

imagen15image15

Claims (1)

imagen1image 1
ES201400512A 2014-06-27 2014-06-27 Canine mammary inflammatory carcinoma cell line Active ES2517190B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201400512A ES2517190B2 (en) 2014-06-27 2014-06-27 Canine mammary inflammatory carcinoma cell line
PCT/ES2015/000080 WO2015197884A1 (en) 2014-06-27 2015-06-19 Cell line of canine inflammatory mammary carcinoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201400512A ES2517190B2 (en) 2014-06-27 2014-06-27 Canine mammary inflammatory carcinoma cell line

Publications (2)

Publication Number Publication Date
ES2517190A1 true ES2517190A1 (en) 2014-10-31
ES2517190B2 ES2517190B2 (en) 2015-05-05

Family

ID=51795084

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201400512A Active ES2517190B2 (en) 2014-06-27 2014-06-27 Canine mammary inflammatory carcinoma cell line

Country Status (2)

Country Link
ES (1) ES2517190B2 (en)
WO (1) WO2015197884A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113980904B (en) * 2021-11-25 2023-11-28 华中农业大学 Canine inflammatory breast cancer cell line and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110085982A1 (en) * 2009-10-09 2011-04-14 Duke University; The Regents of the University of California Dkat cell line, a model for human triple-negative breast cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110085982A1 (en) * 2009-10-09 2011-04-14 Duke University; The Regents of the University of California Dkat cell line, a model for human triple-negative breast cancer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FERNANDEZ S. V., et al. Inflammatory breast cancer (IBC): clues for targeted therapies. Breast cancer research and treatment Netherlands Jul 2013 VOL: 140 No: 1 Pags: 23 - 33 ISSN 1573-7217 (Electrónico) Doi: doi:10.1007/s10549-013-2600-4 pubmed:23784380. Ver todo el documento. *
KIM N. H., et al. Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers. Journal of comparative pathology England May 2013 VOL: 148 No: 4 Pags: 298 - 306 ISSN 1532-3129 (Electrónico) Doi: doi:10.1016/j.jcpa.2012.08.009 pubmed:23079102. Ver todo el documento. *
PINHO S. S., et al. Canine tumors: a spontaneous animal model of human carcinogenesis. Translational research : the journal of laboratory and clinical medicine United States Mar 2012 VOL: 159 No: 3 Pags: 165 - 172 ISSN 1878-1810 (Electrónico) Doi: doi:10.1016/j.trsl.2011.11.005 pubmed:22340765. Ver todo el documento. *

Also Published As

Publication number Publication date
ES2517190B2 (en) 2015-05-05
WO2015197884A1 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
CY1119960T1 (en) METHODS TO INCREASE THE EFFECTIVENESS OF FOLR1 CANCER TREATMENT
CL2016000883A1 (en) Macrocyclic compounds, membrane specific prostate antigen (psma) inhibitors; pharmaceutical composition; metal complex; and its use to prepare radiolabelled compounds useful for imaging to diagnose and for the treatment of prostate cancer and / or metastasis thereof.
ECSP17016797A (en) INDAZOLES SUBSTITUTED WITH BENZYL AS BUB1 INHIBITORS
UY36738A (en) TGR5 MODULATORS AND SAME USE METHODS
MX371312B (en) Pyrazolyl-ureas as kinase inhibitors.
UY35500A (en) INDAZOLS REPLACED WITH HETEROARILO
CL2016000728A1 (en) "Diazacarbazole derived compounds, tau binders; process of preparation of these; and its use as a binder and imager of aggregate of tau, betamiloid or alpha-nucleosin in the diagnosis of Alzheimer's. ” pct
BR112016029860A2 (en) alpha-folate (fra) -receptor anti-receptor antibody conjugates and methods of use
ES2543850A2 (en) Use of sod metal mimetic complexes as food agents and as cosmetics (Machine-translation by Google Translate, not legally binding)
JP2015016294A5 (en)
BR112015016995A8 (en) use of nicotinic acetylcholine alpha 7 receptor agonists
EA201591622A1 (en) KABAZITAXEL AND ITS APPLICATION FOR THE TREATMENT OF METASTATIC CANCER DISEASES OF THE DIVISION
ES2517190A1 (en) Canine mammary inflammatory carcinoma cell line (Machine-translation by Google Translate, not legally binding)
ES2565198T3 (en) Avian metapneumovirus in oncolysis
ES2536842T3 (en) Pharmaceutical composition for cancer treatment
CL2016001054A1 (en) Compounds for the treatment of diabetes and complications of diseases derived from it
EA201792502A1 (en) KABAZITAXEL AND ITS APPLICATIONS FOR CANCER TREATMENT
ES1138710U (en) Anti-ronquido and apnea apparatus. (Machine-translation by Google Translate, not legally binding)
ES2537905A2 (en) Use of 12-deoxiforboles to promote the proliferation of neural stem cells (Machine-translation by Google Translate, not legally binding)
ES1122730U (en) Shoe with parts and replaceable floors. (Machine-translation by Google Translate, not legally binding)
ES2499965A1 (en) Method for the synthesis of homologous compounds of azanucleosides
ES2525772A1 (en) Synthesis and use of perimidinones in disorders of mood and anxiety (Machine-translation by Google Translate, not legally binding)
ES2526935A1 (en) Compounds for the treatment of leishmania infections (Machine-translation by Google Translate, not legally binding)
UA36434S (en) CALCULATOR FOR ASSESSMENT OF THE RISK OF THE DEVELOPMENT OF THE FIRST STROKE IN PATIENTS WITH HYPERTENSION DISEASE
ES1135533U (en) Folding wheelchair (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2517190

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20150505